Methylation status of the SOCS 1 and JUNB genes in chronic myeloid leukemia patients

Revista Brasileira de Hematologia e Hemoterapia

Márcia Cristina R. Pena²  Maria Inês M. C. Pardini¹  Virgilio A. R. Colturato¹  Nídia A. Pinheiro¹ 

[1] ,Universidade Estadual Paulista Faculdade de Medicina de Botucatu Laboratório de HematologiaBotucatu SP

关键词: Chronic myeloid leukemia;    methylation;    MSP- PCR;    SOCS- 1;    JUNB;    Leucemia mieloide crônica;    metilação;    MSP- PCR;    SOCS- 1;    JUNB;   

DOI  :  10.1590/S1516-84842009005000050

来源: SciELO

【 摘 要 】

Alterations in the methylation status of genes may contribute to the progression of Chronic Myeloid Leukemia (CML). In this study, the methylation status in exon2 of SOCS- 1 and promoter regions of both SOCS- 1 and JUNB were evaluated in CML patients. The methylation status of these genes was analyzed using methylation- specific Polymerase Chain Reaction (MSP) in 30 samples from CML patients, 30 samples from these same patients after hematopoietic stem cell transplantation (HSCT) and 30 samples from healthy controls. The samples of CML patients presented methylation as follows: JUNB gene (3.3%), promoter region of the SOCS- 1 gene (6.6%) and exon2 of the SOCS- 1 gene (46.6%). The samples of the healthy individuals presented methylation (10%, P = 0.002) only in exon 2 of the SOCS- 1 gene. After transplantation, patients presented alterations in the methylation status of the promoter region of the SOCS- 1 gene (6.6%), exon2 of SOCS- 1 (46.6%) and the promoter region of the JUNB gene (16.6%). Methylation of the promoter regions of the SOCS- 1 gene and the JUNB gene is not a frequent event in CML. In contrast, SOCS- 1 gene methylation in exon2 is a frequent event, susceptible to alterations in status after HSCT with possible implications for the progression of this disease.

【 授权许可】

CC BY-NC-ND   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License